Determination Of Neutrophil Gelatinase-Associated Lipocalin (Ngal) As A Diagnostic Marker For Renal Disorders

Patent No. EP2128625 (titled "Determination Of Neutrophil Gelatinase-Associated Lipocalin (Ngal) As A Diagnostic Marker For Renal Disorders") was filed by Antibodyshop on Dec 20, 2005. The application was issued on Jan 25, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENTIANOct 25, 2017REITSTOTTER KINZEBACH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2128625

ANTIBODYSHOP
Application Number
EP09154624A
Filing Date
Dec 20, 2005
Status
Opposition Rejected
May 10, 2019
Publication Date
Jan 25, 2017